© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Ceftezole Sodium takes its roots from the early era of cephalosporin antibiotics, which flourished in medical discovery after researchers extracted cephalosporin C from Acremonium in the 1940s. As resistance to penicillins mounted, pharmaceutical scientists searched for safer, less allergenic, and more versatile options. Ceftezole, a first-generation cephalosporin, joined the arsenal in the late 1970s, offering a route toward both efficacy and safety in the fight against Gram-positive and select Gram-negative bacteria. The sodium salt form improved water solubility, facilitating intravenous use and hospital adoption. Labs worldwide used Ceftezole for over a decade before newer generations arrived, but the drug’s initial success laid the foundation for modern beta-lactam therapy.
Ceftezole Sodium is an injectable beta-lactam antibiotic, most often encountered as a sterile powder ready for reconstitution. Hospitals and clinics recognized its reliability against staphylococci and streptococci, especially in preoperative prophylaxis and moderate infections such as respiratory, urinary tract, and skin. During its heyday, Ceftezole gained recognition for rapid bactericidal action and a relatively low risk of allergenic response, opening doors for patients with mild penicillin allergies. Clinicians valued its straightforward dosing and proven track record in controlling surgical site infections. Generating consistent outcomes demanded adequate purity, which manufacturers guaranteed by refining their crystallization and freeze-drying processes.
Ceftezole Sodium forms an off-white to pale yellow powder, highly soluble in water but nearly insoluble in organic solvents like ethanol or chloroform. Its molecular formula—C19H16N5NaO5S2—captures the structure’s hallmark beta-lactam ring, the battle-tested warhead in antibacterial therapy. Chemical stability relies heavily on low moisture and cool storage; high temperatures or humidity tend to degrade the compound’s beta-lactam ring, undermining antimicrobial potency. Sodium, integrated for pharmaceutical usability, determines both ionic strength upon reconstitution and compatibility with standard saline solutions found in most hospital settings.
Pharmacopoeias list Ceftezole Sodium under strict specifications: purity exceeding 98%, with minimal pyrogenicity and defined moisture thresholds under 2.5%. Vials typically carry 1g of active content, labeled for dilution in sterile water, saline, or compatible infusions before injection. Each label must declare batch origin, expiry, recommended storage (generally 2-8°C), and reconstitution guidance. Analytical certificates show tests for heavy metals, bacterial endotoxins, and microbial load, ensuring safety throughout the shelf life. Pharmacists rely on clear, direct language in labeling—ambiguous instructions or inconsistent dosing risks grave harm, especially in high-pressure clinical scenarios.
The process behind Ceftezole Sodium production begins with fermenting a cephalosporin-producing microorganism, often Cephalosporium acremonium. Fermentation broth gets filtered, and cephalosporin intermediates undergo chemical acylation to install the methylthioacetyl group essential for Ceftezole’s antibacterial edge. The purified acid form is then neutralized using sodium hydroxide, forming the sodium salt. Manufacturers emphasize strict temperature and pH regulation, as beta-lactam hydrolysis can ruin yields. Modern production lines deploy vacuum drying, sterile filtration, and meticulous filling under GMP-certified cleanrooms to prevent cross-contamination and meet regulatory standards worldwide.
The molecule’s appeal stems from its amenability to structural tweaking. While Ceftezole itself carries a thiadiazole ring and a methoxyl group responsible for its antibacterial targeting, chemists over the years explored modifications, hoping to extend antibacterial range or improve pharmacokinetics. Slight changes, even the swap of one side-chain, often shift selectivity for enzymes or alter susceptibility to beta-lactamases. The beta-lactam core stays remarkably fragile—excess heat or exposure to acid cleaves it, rendering the product useless. Research spun off analogs with improved resistance to bacterial destruction, ultimately influencing the blueprint for more advanced cephalosporins.
Ceftezole Sodium carries several synonyms across literature and commercial platforms, including Ceftezolum Natricum, CEZ-Na, and by tradenames like Cefzon, Mozen, and others, depending on national regulatory approvals. Each alias tracks the molecular backbone, ensuring pharmacists around the globe can verify ingredient identity, both in import-export documentation and at the bedside. Official pharmacopeial monographs unify standards and support cross-border consistency, crucial when supply chains stretch between continents.
The beta-lactam nature of Ceftezole demands careful handling in hospital pharmacies to prevent unintended exposure for penicillin-allergic staff and patients. Protective gloves, dust control, and sealed vials form part of the safety kit. During intravenous use, practitioners guard against extravasation and anaphylaxis; beta-lactam antibiotics can spark severe reactions in sensitive individuals. Quality standards dictate single-use per reconstituted vial, as room temperature storage after dilution risks bacterial contamination. Environmental agencies regulate effluent disposal, recognizing the threat antibiotic residues pose to wastewater and the rise of resistant bacteria downstream.
Ceftezole Sodium earned accolades in general surgery wards, obstetric suites, and outpatient treatment rooms. Hospitals used it for everything from prophylaxis in orthopedic implants to mastitis and pediatric pneumonia. Its activity window tightly spans Gram-positive cocci, with modest Gram-negative reach—this made the drug a staple preceding more selective antibiotics like vancomycin or advanced quinolones. Limited oral bioavailability kept Ceftezole a product of the intravenous and intramuscular toolkit, reinforcing its use on inpatient floors. Regions with high resistance to older penicillins and cephalosporins still see value in legacy products like Ceftezole, providing affordable options compared to costlier, next-generation drugs.
Ceftezole’s legacy features decades of scientific scrutiny, from classic MIC (minimum inhibitory concentration) mapping onwards. Researchers quantified its binding strength to penicillin-binding proteins, and epidemiologists catalogued resistance trends after commercial rollout. Over time, labs traced mechanisms by which bacteria—most notably Enterobacteriaceae—dodged Ceftezole’s attack, spurring investigations into beta-lactamase inhibitors and combinatory regimens. Even as hospitals pivoted toward newer agents, trial data continued to enrich understanding of cephalosporin pharmacology. Modern study seeks better delivery matrices, like sustained-release or liposomal forms, hoping to stretch Ceftezole’s relevance in resource-limited settings.
Safety data for Ceftezole Sodium extends from the initial animal trials through decades of clinical observation. Animal studies revealed low acute toxicity, but allergic reactions and kidney stress at high doses saw careful monitoring in humans. Nephrotoxicity remains a concern at high serum concentrations, especially in patients with renal impairment. Toxicologists warn of cross-reactivity with other beta-lactams, meaning a history of serious penicillin allergy may pose unacceptable risks. Modern protocols require early detection of urticaria, bronchospasm, or serum sickness, all reported in rare cases. Authorities also track long-term ecological toxicity, worried about antibiotics in aquatic ecosystems nudging forward the next generation of resistant superbugs.
Ceftezole Sodium occupies a challenging spot in today’s landscape. While much of the world adopts broader-spectrum, more robust cephalosporins, Ceftezole weighs in with value for targeted, cost-conscious care—especially in places facing budget constraints or high rates of hospital-acquired infections. Ideas for extending utility abound, from new combinatory therapies to innovative delivery systems reducing dosage and frequency. Regulatory agencies increasingly focus on sustainable antibiotic stewardship; Ceftezole, with its well-understood profile and targeted spectrum, could serve as an anchor for step-down therapy after culture results arrive. Ongoing resistance monitoring, public health education, and industry investment in alternative formulation keep Ceftezole relevant, even as medicine contends with an ever-shifting antibiotic resistance crisis and rising development costs in the pharmaceutical industry.
Ceftezole Sodium belongs to a group of medicines known as cephalosporin antibiotics. Doctors reach for it to tackle infections caused by bacteria. Not all bugs respond well to every drug, so choosing the right one carries a lot of weight for patient recovery. Ceftezole has proven itself especially helpful for conditions running the spectrum from pneumonia, urinary tract infection, to skin and soft tissue infections. It gets administered by injection—usually in hospitals—making it an option for folks who can’t manage oral medications or who need a strong solution right away.
When a person lands in the hospital with a nasty infection, rapid treatment can mean the difference between a long stay and a timely recovery. I’ve seen cases where someone shows up with a persistent wound infection that just won’t quit, and time is ticking. After checking lab results, doctors might pick Ceftezole Sodium based on the bug identified. It works by breaking down the wall of the bacteria, leading to their death. This direct approach keeps the infection from spreading and lets the body start healing.
Using antibiotics responsibly matters more than ever. The world deals with germs that don’t die off easily because of resistance—something fueled by overuse or the wrong choice of drug. Ceftezole Sodium is not a household name, but it plays a role in treating tough situations. When over-prescribed, even good medicines like Ceftezole lose their firepower over time. At clinics I’ve worked in, we lean on culture and sensitivity tests to decide if Ceftezole really stands as the right choice. Studies, including recent ones cited by the World Health Organization, highlight rising antibiotic resistance as a threat we shouldn’t ignore.
Side effects come with many antibiotics, Ceftezole Sodium included. Some people notice reactions like rash or upset stomach. On rare occasions, allergic responses or changes to kidney function set in, especially if other health conditions join the mix. Healthcare teams monitor closely, especially for folks with chronic illness or older age. Having seen allergic reactions firsthand, extra care with patient history avoids unnecessary risks.
Addressing the threat of antibiotic resistance goes beyond the prescribing hand. Hospitals and clinics step up by monitoring treatments, training staff, and keeping a close eye on local resistance trends. Meanwhile, patients play a role by finishing their prescribed course. Quick improvement can tempt people to stop meds early, but this sets the stage for bacteria to survive and get stronger the next round. By sharing these practical lessons in clinics and community education, fewer doses get wasted.
Ceftezole Sodium’s benefit shines brightest as part of a thoughtful treatment plan guided by solid evidence. Leaning on lab data and patient history ensures its use targets the right bug for the right reason. Research shows that timely, informed antibiotic choices speed up recovery and cut back on serious complications. In today’s world, sticking with this kind of careful medicine helps protect our most precious weapon against infection—not just for the patient in the hospital bed, but for everyone down the road.
Doctors prescribe Ceftezole Sodium for fighting off bacterial infections. It belongs to a group of antibiotics called cephalosporins. Instead of popping a pill, this medicine gets into the body through injections. I’ve seen doctors and nurses prepare it right before giving it to a patient, often in emergency rooms where infections need quick attention.
Hospital staff start by reconstituting the powder with sterile water or saline, making it suitable for injection. It always surprises folks how just a tiny vial of powder can become lifesaving treatment in a matter of minutes. The healthcare provider injects it either directly into a vein (intravenous) or into the muscle (intramuscular). Intravenous use makes sense for patients who are quite ill, since this route gets the drug into the bloodstream fast and keeps levels steady. In less urgent cases or for continued therapy, intramuscular shots may be used.
This drug does not work by osmosis from a pill or patch; needles get the job done. I remember working with a patient who despised needles but needed fast action for a skin infection. Teaching him about why Ceftezole Sodium can't go by mouth cleared up a lot of questions, especially about why some medicines must bypass the gut and work quickly right where bacteria linger.
Administering antibiotics correctly is not just prescription formality. Giving medicine by injection lets doctors control the dosage and ensure the right tissue levels. Pharmacies supply single-use powder vials to reduce contamination risks. Once dissolved, the nurse draws up the solution in a syringe. Clean technique matters here; infections caught in hospitals too often stem from skipped steps in the injection process.
Side effects sometimes follow. Redness and pain crop up at the injection site more with intramuscular shots than intravenous ones. Allergic reactions happen rarely, but nurses keep an eye out just in case. I've learned to respect the sensitivity of the human body to antibiotics, even ones used safely for decades.
Time pressure and busy wards can create room for errors. Mixing guidelines must be clear; labeling has to stay unambiguous. Early in my hospital days, I saw a nurse double-check every detail against patient charts, including whether an individual had any allergy to cephalosporins. Those habits prevent harm before the medicine enters a vein or muscle.
In rural clinics, shortages of staff or supplies sometimes limit how often injections occur. Some hospitals rotate antibiotics based on inventory, not just clinical need. Investment in better supply chains could smooth out these wrinkles. Patients and families ask questions about each step, usually focused on safety and timing. Being transparent with patients has only ever built more trust in my experience, especially as more people manage chronic infections or spend time in hospitals.
Ceftezole Sodium sticks around as a useful tool against bacteria. Safe administration flows from skilled training and steady supply chains. Open communication among nurses, doctors, and patients strengthens outcomes and reduces risks that pile up when corners get cut. Patients do best when every step, from powder to injection, happens with care and understanding.
Antibiotics have become a regular part of health care. It’s easy to pick up a prescription when fighting off an infection. Ceftezole Sodium falls under this umbrella, often used in hospitals to knock out bacterial infections. Like any powerful tool, it comes with its own set of bumps in the road.
Stomach issues top the list for this drug, something almost everyone who’s dealt with antibiotics knows all too well. Nausea and diarrhea seem to follow many prescriptions, and Ceftezole isn’t an exception. Upset stomach makes it hard to get through daily routines, and no one likes extra trips to the bathroom. In rare cases, people might see vomiting or loose stools that won’t stop. For folks who rely on a regular schedule, these side effects can make it harder to work, care for kids, or just enjoy a meal.
Some patients pick up skin rashes after a dose or two, those itchy red patches that can make sleeping and focusing a chore. Allergic reactions stand out most with hives, swelling of the face, and sometimes trouble breathing. These allergic symptoms need quick attention. The U.S. Food and Drug Administration points out that severe reactions are rare, but not impossible. If someone already deals with allergies, it smart to mention it before starting any new medicine.
Yeast infections sometimes pop up when antibiotics mess with the body’s natural bacteria balance. For some, this means oral thrush, white patches in the mouth, or vaginal itching and discharge. Women seem to carry more of this burden because the change in normal bacteria hits hard.
Though not everyday events, a drop in white blood cell count sometimes happens. That can leave the immune system weaker for a stretch. Some people feel especially tired or pick up more colds than usual after a course of antibiotics. Lab checks designed for patients on long-term therapy can catch changes in blood cells or kidney numbers before they get serious.
Severe intestinal issues carry the most concern. Clostridium difficile infection usually brings more serious, sometimes bloody diarrhea with stomach cramps. Hospitals flag this reaction because it spreads easily, and people with weaker immune systems or older adults face more risk. Quick treatment stops this spiraling into something worse.
Doctors and patients both play a role in managing side effects. Be honest about anything strange that shows up after starting new medicine. Explain discomfort right away, whether it’s skin, stomach, or breathing related. Ask questions about mixing antibiotics with other prescriptions, especially if taking medicines for chronic diseases.
Hydration helps with milder side effects like nausea and diarrhea. Eating a bland diet sometimes keeps symptoms manageable until the medicine runs its course. Probiotics or yogurt can offer relief for digestive symptoms, though it's best to check with a doctor first, especially for those with health problems or immune concerns.
People should keep a close line of communication with health providers. Pharmacists stand ready for questions about timing, symptoms, or what to do if a dose seems too strong. Understanding the risks lets families spot trouble early and make smart decisions about care.
I’ve seen firsthand how antibiotics work wonders for tough infections, but they’re not for everyone. Ceftezole sodium, a member of the cephalosporin family, has saved many from the grip of bacterial invaders. The catch is, certain groups need to steer clear or check in with their doctor before picking up a prescription.
People with a history of allergic reactions to cephalosporin antibiotics need to take extra care. This group faces a higher chance of experiencing rashes, swelling, and even life-threatening anaphylaxis. If someone’s had trouble with penicillins, caution dominates the conversation. Cross-reactivity between penicillins and cephalosporins pops up, especially for those who’ve blown up with hives or breathing problems after a penicillin shot. The safest route stays total avoidance, and letting any healthcare provider know about past allergies.
The kidneys handle most of the heavy lifting when flushing out ceftezole sodium. Folks with kidney problems or chronic kidney disease can’t clear the drug as efficiently. The antibiotic can accumulate, which raises the risk for side effects like seizures or brain fog. Dose adjustments offer one workaround, but sometimes doctors recommend different antibiotics. Blood tests tracking kidney filters, like creatinine, help steer the right dose and keep things safe.
Antibiotics sweep away harmful bacteria, but sometimes good bacteria get caught in the crossfire. People with a history of colitis or other gut troubles need extra attention. Certain antibiotics can trigger a return of inflammation in the colon, or unleash a tough customer called Clostridioides difficile. Symptoms like persistent diarrhea, fever, or blood in the stool after a course of ceftezole need quick action, not patience at home.
Children and older adults have more sensitive systems. Kids still fine-tune their kidney function, and older adults see a slowdown. Each group is more at risk for side effects like seizures or allergic reactions. Careful dosing and clear communication with a specialist about any unusual symptoms or confusion during treatment always help.
Pregnant women worry about every medication. Studies on ceftezole sodium during pregnancy haven’t raised big alarms, but doctors weigh the benefits against possible risks. If there are better-studied antibiotics for a certain infection, those take the spotlight. Nursing mothers pass a small amount of the drug to infants via breastmilk. Babies need to be watched for rashes or tummy upsets, and some doctors may suggest switching antibiotics or formula for a short time.
Starting antibiotics isn't a light decision. Telling doctors about allergies, kidney problems, gut history, or anything unusual goes a long way. Even basic things like sharing every pill or supplement, including over-the-counter ones, help prevent conflicts. Antibiotic stewardship also plays a part: don’t save leftovers or share antibiotics with friends and family. Encourage open dialogue and follow up with doctors if symptoms stay the same or get worse. These habits not only keep immediate risks in check but also make it harder for bacteria to outsmart our medicine cabinet in the long run.
Pregnancy and breastfeeding can pile questions on even the most straightforward health problems. Often it feels like every common medicine turns into a loaded decision. As a parent, you feel the weight of choosing the best path for both your own health and your child’s well-being. Among many antibiotics on pharmacy shelves, ceftezole sodium pops up as an option healthcare providers may raise for bacterial infections. It has been around since the 1970s, which means there’s plenty of information to sift through but also gaps that deserve attention—especially when pregnancy or breastfeeding is in the picture.
Most of what doctors know about ceftezole sodium during pregnancy comes from animal studies and a handful of scattered human cases. The U.S. Food and Drug Administration does not list ceftezole on its current pregnancy risk categories since those were revised, but older resources classified similar drugs as Category B. In short, these antibiotics did not show direct harm in animal studies, and human evidence remains limited.
No research so far ties ceftezole sodium to birth defects or miscarriage when used during pregnancy. Still, large-scale studies remain missing. That gap leaves everyone—doctors and patients—leaning on years of cautious prescribing, prioritizing drugs with the most evidence first. At the end of the day, the benefit must clearly outweigh any unknowns, and in life-threatening infections, sometimes this calculus shifts.
I’ve seen expectant mothers who face tough choices with infection management. Some have tried standard antibiotics and found little relief, or developed allergies. In rare cases, ceftezole came up as the next line because it stands as a broad-spectrum cephalosporin, useful when other options fall short. Doctors prefer antibiotics they’ve seen work safely over decades, like penicillins or amoxicillin, but not every patient fits that familiar mold.
A close family member once dealt with a bacterial infection midway through pregnancy. Alternatives like ceftezole entered the conversation. Her doctor walked her through the pros and cons, the lack of hard data, the history of safe use in hospitals, and the need for strict monitoring. The process was not about easy answers but about making the best choice with the facts on hand.
Mothers who breastfeed want reassurance that what they take will not land in their baby’s system in harmful quantities. Ceftezole, like many cephalosporins, passes into breast milk in small amounts. So far, reported problems in infants are rare. Occasionally, loose stools or a rash show up in breastfed babies, but these usually clear up quickly. Doctors will sometimes suggest watching the child for signs of tummy trouble or yeast infections. If an infection in the mother can’t be managed with other antibiotics, ceftezole might make sense after talking through alternatives.
Risks and benefits carry real weight. Open discussion between patients and providers becomes the foundation. Having worked with families through these moments, I’ve come to appreciate the need for up-to-date, honest guidance. Every decision involves looking at symptoms, the severity of infection, personal allergies, and other health concerns. Sticking close to trusted medical support gives the best chance for both mother and child to thrive. It all boils down to individualized care, reliable advice, and clear communication at every step.
| Names | |
| Preferred IUPAC name | sodium (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| Other names |
Ceftezol Sodium Ceftezole Na Sodium ceftezole |
| Pronunciation | /ˈsɛf.tɪˌzoʊl ˈsoʊ.di.əm/ |
| Identifiers | |
| CAS Number | [72558-82-8] |
| Beilstein Reference | 127368 |
| ChEBI | CHEBI:3494 |
| ChEMBL | CHEMBL2106028 |
| ChemSpider | 187463 |
| DrugBank | DB01330 |
| ECHA InfoCard | echa.europa.eu/substance-information/-/substanceinfo/100.064.254 |
| EC Number | 37321-67-6 |
| Gmelin Reference | 88857 |
| KEGG | D03508 |
| MeSH | D002493 |
| PubChem CID | 656834 |
| RTECS number | XG6158000 |
| UNII | SY2Z9S2VYF |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C18H15N8NaO5S3 |
| Molar mass | 421.36 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.73 g/cm3 |
| Solubility in water | Soluble in water |
| log P | -2.6 |
| Acidity (pKa) | 2.5 |
| Basicity (pKb) | 7.7 |
| Magnetic susceptibility (χ) | -4.6 x 10^-6 cm^3/mol |
| Dipole moment | 3.98 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | Std molar entropy (S⦵298) of Ceftezole Sodium is 0 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | J01DB11 |
| Hazards | |
| Main hazards | May cause allergic reactions, respiratory tract irritation, gastrointestinal disturbance, and skin or eye irritation. |
| GHS labelling | GHS07, GHS05 |
| Pictograms | pictograms: ["GHS07"] |
| Signal word | Warning |
| Hazard statements | Hazard statements: May cause an allergic skin reaction. |
| Precautionary statements | Store below 30°C. Protect from light. Keep out of reach of children. For hospital use only. |
| NFPA 704 (fire diamond) | 1-1-0 |
| Lethal dose or concentration | LD50 intravenous, mouse: 4000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse (IV) 5000 mg/kg |
| PEL (Permissible) | PEL (Permissible exposure limit) for Ceftezole Sodium: Not established |
| REL (Recommended) | 1–2 g every 8–12 hours |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Cefazolin Ceftezole Cefotaxime Cefalexin Cephalothin |
